TrialThe oncologist2026

Use of liposomal irinotecan with 5-FU and oxaliplatin (NALIRIFOX) in neoadjuvant pancreatic adenocarcinoma: NEO-Nal-IRI trial.

Thomas J George et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.